Brief: Cipher Pharma comments on FDA warning letter for ConZip(Tramadol)
07/09/2017 12:05
Sept 7 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO
* Cipher Pharma- commented on warning letter issued to co
by FDA relating to professional detail aids for ConZip
extended-release capsules
* Cipher Pharmaceuticals - Vertical Pharma informed co has
taken immediate corrective actions, ceasing distribution of
ConZip promotional material
Source text for Eikon: ID:nCNWYK6GRa
Further company coverage: CPH.TO
(((Bangalore.newsroom@thomsonreuters.com;);))
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million